niftycupblog

Featured resource

accesswebinar

A new GHTC webinar—Achieving access to new innovations—discusses the challenges that hinder the development of and access to new global health technologies and the different approaches being taken in the R&D process to overcome these challenges and achieve widespread access.

Stay up-to-date

EmailOur monthly e-newsletter includes global health research and development features, events, and media coverage, as well as member information.

Twitter

Facebook

YouTube

Annual policy report

ghtc full report 2015Each year, the GHTC releases a policy report that includes recommendations for how US policymakers can continue to advance innovation and save lives around the world. A print summary version (2.2 MB PDF) of the report is also available.

GHTC Member spotlight

MMV

DNDi


The Drugs for Neglected Disease initiative and the Medicines for Malaria Venture have teamed up to ensure two treatments for malaria continue to reach the patients who need them most. The treatments—two fixed-dose artemisinin combination therapies known as ASAQ and ASMQ—were developed by DNDi and partners and launched in 2007 and 2008, respectively; going forward, MMV will work with those partners to ensure these drugs remain available and accessible in countries where they are most needed.

More about this announcement

More about our members

More about GHTC

Sign up for the GHTC newsletter Follow us

Home | Contact us | Privacy policy | Copyright policy

© 2009–2015, Global Health Technologies Coalition.